Tarrano, Clément
Galléa, Cécile
Delorme, Cécile
McGovern, Eavan M.
Atkinson-Clement, Cyril
Brochard, Vanessa
Thobois, Stéphane
Tranchant, Christine
Grabli, David
Degos, Bertrand
Corvol, Jean Christophe
Pedespan, Jean-Michel
Krystkowiak, Pierre
Houeto, Jean-Luc
Degardin, Adrian
Defebvre, Luc
Beranger, Benoit
Martino, Davide
Apartis, Emmanuelle
Vidailhet, Marie
Roze, Emmanuel
Worbe, Yulia
Funding for this research was provided by:
Dystonia Medical Research Foundation
European Commission (EJP RD COFUND-EJP N° 825575 – EurDyscover)
AMADYS (Fonds de Dotation Brou de Laurière)
Article History
Received: 27 March 2024
Accepted: 17 September 2024
First Online: 27 September 2024
Declarations
:
: C. Galléa, C. Tranchant, B. Beranger, V. Brochard, C. Atkinson-Clement, L. Defebvre, P. Krystkowiak, J-L. Houeto, J.C. Corvol, E. Apartis, D. Martino, (A) Degardin, J-M Pedespan, M. Vidailhet, Y. Worbe have no disclosures in relation to this work.C. Tarrano received a PhD grant from the “Fondation pour la Recherche Médicale”. C. Delorme has received travel funding from Merz Pharma, Abbvie, and received honoraria from Merz Pharma. (B) Degos received honoraria for acting as a member of Scientific Advisory Boards/Consultancy for Merz Pharma, speaker honoraria from Merz Pharma, Abbvie and Ipsen, and travel support for congresses from Merz Pharma. S. Thobois received honorarium from Abbvie and Merz. E. McGovern has received speaking honoraria from AbbVie, Dutch MDS symposium, served on an advisory board for AbbVie and received research grants from the STAR MD and the RCSI Richard Steeven’s Scholarship. D Grabli served on scientific advisory boards for AbbVie, received speech honoraria from Abbvie, Merz and received travel funding from Abbvie and Merz. E.Roze. received honorarium for participating in an advisory board from Merz-Pharma, received research support from Merz-Pharma, Ipsen, AMADYS, Agence Nationale de la Recherche, Societé Française de Médecine Esthétique, Dystonia Medical Reasearch Foundation.
: .